3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Classical hematology
1
Conditions
Thrombocytopenia
1
Recurrence
1
Ovarian Neoplasms
1
Interventions
niraparib
4
olaparib
2
apatinib
2
Sevoflurane
2
Saline Solution
2
Propofol
2
Carboplatin
2
Bevacizumab
2
pegylated granulocyte colony-stimulating factor
1
pegfilgrastim
1
pazopanib
1
palbociclib
1
liposomal doxorubicin
1
lenvatinib
1
gadofosveset trisodium
1
fosaprepitant
1
ferrous fumarate
1
Tranexamic Acid
1
Trabectedin
1
Sunitinib
1
Sodium Chloride
1
Pharmacokinetics
1
Patient-Specific Modeling
1
Pafolacianine
1
Paclitaxel
1
LY 353381
1
Injections
1
Indocyanine Green
1
Folic Acid
1
Dexamethasone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Ovarian Neoplasms
×
Pharmacokinetics
×
Clear all
NCT04861181
2025-05-22
NIRAPK
Hospices Civils de Lyon
Phase 4
Terminated
12 enrolled